State University of New York at Buffalo
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, State University of New York at Buffalo sits in the top decile of US sponsors by registered trial count (#135 of 15,742 sponsors by registered trial count).
State University of New York at Buffalo: 243 sponsored US clinical trials, 52 recruiting.
State University of New York at Buffalo sponsors 243 registered US clinical trials on ClinicalTrials.gov, 52 of them currently recruiting, and 156 completed. 19 of these trials are in Phase 3-4 (later-stage) and 26 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Multiple Sclerosis, with 4 trials.
Top-decile sponsor footprint
State University of New York at Buffalo ranks in the top decile of sponsors by registered trial count (#135 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
156 of 172 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
243 total, page 3 of 5
Work-To-Rest Ratios
NCT05327764
Prevention of Alcohol-related Sexual Revictimization in College
NCT05257603
Vulvodynia Pain Thresholds
NCT04461210
Carriere Motion Appliance* Versus In-office Sectional Appliance
NCT05204654
Reinforcing CP Robotic Training With Auditory Feedback
NCT05335798
Study to Assess the Efficacy of Mayzent on Microglia in Secondary Progressive Multiple Sclerosis
NCT04925557
The Intersection Between Loss of Control Eating and Obesity: The Role of Restriction and Food Reinforcement
NCT05177705
Technology-assisted Conscientiousness Therapy for People With Multiple Sclerosis
NCT04953689
Home-Based Dual-Task Training for Older Adults
NCT05108246
Protecting Allies in Risky Situations
NCT04691492
Mellowing Mind: Comparing Two Technology Based Mindfulness Interventions for Stress Impacted by COVID-19 in Underserved Communities
NCT05180513
Family History and Breast Cancer Education Trial
NCT05186727
The Effects of the Be Mindful Intervention in Previously Depressed Individuals Experiencing Subclinical Symptoms
NCT04740879
The Relationship Between Panic Attack Symptoms and Atrial Fibrillation Episodes.
NCT04634461
The Get Outside Study
NCT04685681
Laser Dosage in MicroPulse TransScleral CycloPhotocoagulation
NCT04709679
Multimodal Pain Management After Robotic-Assisted Total Laparoscopic Hysterectomy
NCT04429022
Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19
NCT04474483
Natural History Study of SLC25A46 Mutation-related Mitochondriopathy
NCT04594590
Natural History Study of FDXR Mutation-related Mitochondriopathy
NCT04580979
Oxygenation Changes After 2-month Exercise in Sedentary Older Adults With Diabetes
NCT04626453
Computer Based Newsletter and Literacy Engagement of Middle-school Students
NCT04511065
Using a Nurse-Led Communication Strategy for Surrogates in the Intensive Care Unit
NCT03770481
A Comparison Between GUMMETAL and SS Orthodontic Wires in Space Closure
NCT04591080
Baerveldt 350 vs Ahmed ClearPath 250 for the Treatment of Glaucoma
NCT04542616
BRIUS Vs FFA Efficiency
NCT04347018
The Play With Me Study
NCT04280198
Tarp Assisted Cooling of Hyperthermic Individuals
NCT04095403
Home-based Diabetes-Modified Behavioral Activation Treatment for Low Income Seniors With T2DM
NCT04203147
Comparison of Fatigue in Varying Hot Environments
NCT04624919
Simulation of Consecutive Day Shift Work
NCT04625634
Hepatitis C-Video vs. Brochure Education Delivery
NCT04204447
Meniscus Surgery Registry
NCT04153643
Promoting Healthier Eating Among Children in Restaurants
NCT04334525
Effect of Ultrasound Therapy on Bilateral Masseter Myalgia: Comparison of 1 Megahertz Versus 3 Megahertz
NCT04086862
Cold Water Immersion Stirring in Hyperthermic Individuals
NCT04613843
Effects of Lithium Therapy on Blood-based Therapeutic Targets in Parkinson's Disease.
NCT04273932
CTSI Pilot: Improving Adherence to Diabetic Diet
NCT04051008
E-Health Coping Skills Training for Women Whose Partner Has a Drinking Problem
NCT02984241
Occupational Therapy-based Literacy Intervention and Classroom Based Literacy Intervention
NCT03975972
Imagine to Remember: Improving Medication Adherence in Pre- and Type 2 Diabetes
NCT04157673
Clinical Trial Testing Buzzy Bee vs Vapocoolant During IV Placement
NCT06182631
Oxygenation and Muscle Function's Relationship During SLIE in Older Adults
NCT04812288
Brief Behavioral Treatment for Insomnia in Cancer Survivors
NCT03810365
Early Detection of Respiratory Compromise to Prevent Harm of the Hospitalized Opioid Treated Patient
NCT03968094
Episodic Future Thinking and Weight-Loss
NCT03731325
Water Bolus Volumes During Continuous Exercise in Heat
NCT04613856
Living Donation and Kidney Transplantation Information
NCT04285203
Baby Bump Lifestyle Intervention Supplement Study
NCT03751813
Effect of Intra-subject Phaco/Trabectome vs. Phaco/Kahook Dual Blade on Intraocular Pressure
NCT03894631
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 11 |
| Phase 2 | 15 |
| Phase 3 | 7 |
| Phase 4 | 12 |
What is open in the State University of New York at Buffalo pipeline
52 recruiting of 243 indexed (21% open); 156 completed (64%).
Phase mix: 19 late (III/IV) vs 26 early (I/II) (balanced across stages).
Top condition: Multiple Sclerosis (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
State University of New York at Buffalo: open-pipeline peers nationwide
Peers matched on 243 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
State University of New York at Buffalo sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 243 trials (± recruiting share)
- Shire · 245 trials · 0% recruiting
- University of Cincinnati · 245 trials · 14% recruiting
- University of Massachusetts, Worcester · 240 trials · 13% recruiting
- Incyte Corporation · 239 trials · 15% recruiting
Sponsors near 21% open enrollment (± trial volume)
- Axsome Therapeutics · 21% recruiting · 28 trials
- GOG Foundation · 21% recruiting · 14 trials
- Kettering Health Network · 21% recruiting · 14 trials
- LifeBridge Health · 21% recruiting · 14 trials
Related
What to do with this State University of New York at Buffalo page
243 registered trials is a research-attention snapshot, not an endorsement of State University of New York at Buffalo or any single study.
- 52 of State University of New York at Buffalo's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Multiple Sclerosis is the condition State University of New York at Buffalo studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Multiple Sclerosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
State University of New York at Buffalo pipeline card: 243 registered trials from official public datasets.Report a data error.